Belzutifan is really a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors might raise incidence or severity of adverse consequences. Monitor for anemia and hypoxia and lower belzutifan dose as encouraged. apalutamide will lower the extent or effect of modafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. https://modafinil55310.get-blogging.com/26581116/facts-about-modafinil-revealed